Aurinia Pharmaceuticals Inc公布了其截至2025年12月31日的第四季度及全年财务报告。与此同时,公司还向市场同步了其在近期取得的一系列重要业务进展。
Aurinia Pharmaceuticals Inc公布了其截至2025年12月31日的第四季度及全年财务报告。与此同时,公司还向市场同步了其在近期取得的一系列重要业务进展。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.